| 23-May-2023 | D | The Board of Directors at their meeting held on 23rd May, 2023 recommended a dividend of Rs.14.40 per equity share of Rs.10/- each.
The Board of Directors of the Company, at their meeting held on 23rd May, 2023, fixed the book closure date starting from Thursday, 20th July, 2023 to Wednesday, 26th July, 2023 (both days inclusive) for the purpose of payment of dividend, as recommended in the same meeting. The Board has also, fixed the cut-off date as Wednesday, 19th July, 2023, for the purpose of determining the eligibility of Shareholders eligible for remote e-voting or e-voting during the 38th AGM, scheduled on Wednesday, 26th July, 2023.
| 19-Jul-2023 | |
| 27-May-2022 | D | The Board of directors at their meeting held on 27th May, 2022 recommended a dividend of Rs.12/- (120%) per Rs.10/- paid-up 4589378 equity shares of the Company. | 21-Jul-2022 | |
| 02-Jun-2021 | D | Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 02, 2021, inter alia, have recommended a dividend of Rs.10.20 (102%) per equity share of Rs.10/- each on 4589378 equity shares of the Company. | 30-Aug-2021 | |
| 06-Mar-2020 | D | The Board of Directors of the Company have declared an interim dividend of Rs.8.10 on 4589378 equity shares of the Company. | 18-Mar-2020 | |
| 28-May-2019 | D | Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 28, 2019, inter alia, has recommended a Final Dividend of Rs. 10.20 (102%) per equity share of Rs.10/- each on 4589378 equity shares of the Company. | 22-Jul-2019 | |
| 29-May-2018 | D | Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2018, inter alia, has transacted the following:
- A Final Dividend of Rs. 6.00 (60%) per equity share of Rs. 10/- each has been recommended by the Board, on 4589378 equity shares of the Company. The total dividend, including interim dividend of Rs. 3/- per equity shares, is Rs. 9/- per equity shares of the Company for the financial year 2017-18. | 23-Jul-2018 | |
| 20-Mar-2018 | D | Board of Directors of the Company at their meeting held today i.e. 20.03.2018 have declared the Interim Dividend of Rs.3.00 (i.e. 30%) per equity share. | 27-Mar-2018 | |
| 30-May-2017 | D | Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2017, inter alia, has:
- A Dividend of Rs. 8.10 (81%) per equity share of Rs. 10/- each has been recommended by the Board. | 21-Jul-2017 | |
| 30-May-2016 | D | Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2016, has transacted the following:
1. A Final Dividend of Rs. 0.90 (9%) per equity share of Rs. 10/- each has been recommended by the Board. | 19-Jul-2016 | |
| 10-Mar-2016 | D | Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 10, 2016, have declared the Interim Dividend of Rs. 6.30 (i.e. 63%) per equity share of Rs. 10/- each for the financial year 2015-16.
The interim Dividend shall be paid on or after March 28, 2016. | 17-Mar-2016 | |
| 21-May-2015 | D | Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 21, 2015, inter alia, have transacted the following :
A Dividend of Rs.6.30 (63%) per equity share of Rs.10/- each has been recommended by the Board. | 31-Aug-2015 | |
| 30-May-2014 | D | Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has recommended a Dividend of Rs. 5.10 (51%) per equity share of Rs. 10/- each. | 03-Sep-2014 | |
| 30-May-2013 | D | Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has been recommended a Dividend of Rs. 4.20 (42%) per equity share of Rs. 10/- each.
The dividend, if any, declared at the ensuing Annual General Meeting scheduled on July 31, 2013, will be paid on or after August 13, 2013. | 18-Sep-2013 | |
| 26-May-2012 | D | Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2012, inter alia, has recommended a dividend of Rs. 3.50 (35%) per equity share of Rs. 10/- each. | 23-Jul-2012 | |
| 27-Jun-2011 | D | Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 25, 2011, inter alia, has recommended a Dividend of Rs. 3.50 (35%) per equity share of Rs. 10/- each. | 21-Jul-2011 | |
| 28-May-2010 | D | Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2010, inter alia, has recommended a dividend of Rs. 3.00 (30%) per equity shares of Rs. 10/- each. | 21-Jul-2010 | |
| 23-Jun-2009 | D | Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 23, 2009, inter alia, has recommended a dividend of Rs 1.80 (18%) per equity share of Rs 10/- each. | 23-Jul-2009 | |
| 26-Jun-2008 | D | Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 24, 2008, inter alia, has recommended a dividend of 12.5% equity share of Rs 10/-. | 23-Jul-2008 | |
| 03-Jun-2007 | D | Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 02, 2007, inter alia, has transacted the following:
1. Recommended a dividend of 12.5% per equity share of Rs 10/- each. | 18-Jul-2007 | |
| 22-Oct-2005 | D | 10% Dividend | 10-Aug-2005 | |
| 12-Apr-2024 | BC | Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we hereby inform you about the Changes in Senior Management personne | 12-Apr-2024 | |
| 19-Jan-2024 | BC | JENBURKT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve the Standalone unaudited financia | 06-Feb-2024 | |
| 27-Oct-2023 | BC | JENBURKT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve unaudited financial results for t | 07-Nov-2023 | |
| 25-Jul-2023 | BC | JENBURKT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2023 inter alia to consider and approve standalone unaudited financial re | 08-Aug-2023 | |
| 23-May-2023 | BC | The Board of Directors of the Company, at their meeting held on 23rd May, 2023, fixed the book closure date starting from Thursday, 20th July, 2023 to Wednesday, 26th July, 2023 (both days inclusive) | 26-Jul-2023 | |